Interestingly, principal components analysis revealed that expression patterns were remarkably similar between the CD34+CD38−ALDHhigh cells from CML patients and those from normal donors. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.